Fredun Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Fredun Pharma	Jagsonpal Pharma	Syncom Formulations
Operational Metrics
Financials
5 yr Average ROE	11.84 %	16.01 %	9.79 %
5yr average Equity Multiplier	2.85	1.27	1.41
5yr Average Asset Turnover Ratio	1.08	1.09	0.81
5yr Avg Net Profit Margin	3.9 %	12.08 %	8.78 %
Price to Book	4.75	4.78	3.35
P/E	40.5	30.62	18.28
5yr Avg Cash Conversion Cycle	175.29 Days	2.39 Days	61.57 Days
Inventory Days	146.68 Days	31.56 Days	27.32 Days
Days Receivable	142.46 Days	15.63 Days	82.75 Days
Days Payable	112.95 Days	59.94 Days	79.41 Days
5yr Average Interest Coverage Ratio	2.62	66.99	31.44
5yr Avg ROCE	22.71 %	18.99 %	13.63 %
5yr Avg Operating Profit Margin	9.7 %	13.23 %	9.97 %
5 yr average Debt to Equity	0.93	0.01	0.19
5yr CAGR Net Profit	25.5 %	26.54 %	36.24 %
5yr Average Return on Assets	4.18 %	12.71 %	7.11 %
Shareholdings
Promoter Holding	44.17 %	67.89 %	50.57 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-5.98 %	-0.82 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Fredun Pharma	Jagsonpal Pharma	Syncom Formulations
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals 0 Renting of Property 0 Trading of Commodities 0 Pharmaceutical Drugs & Formulations 0	Product Wise Break-Up Pharmaceuticals 100.0 Pharmaceutical Drugs & Formulations 0 Trading of Commodities 0 Pharmaceutical 0 Renting of Property 0	Product Wise Break-Up Pharmaceuticals 0 Pharmaceutical 99.26 Commodity 0.01 Pharmaceutical 0 Rental Income 0.73
Location Wise Break-Up	Location Wise Break-Up India 83.13 Rest of the World 16.86 Domestic 0 International 0 Others 0.01	Location Wise Break-Up India 0 India 98.7 Rest of the World 0 International 0 Others 1.3	Location Wise Break-Up India 0 Domestic 15.5 Rest of the World 0 International 84.5